Loading

ABCL — AbCellera Biologics Inc. · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

ABCL

AbCellera Biologics Inc.D4515-min delayed · EOD close

12.27▼ −6.19% downas of 2026-10-30mkt cap $3.8B

Pharmaceutical Preparations · SIC 2834 · CIK 0001703057

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Market cap

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

$3.8B

P/E

—

Net margin

-248.8%

ROE

-18.4%

Revenue

$66.2M

latest annual

Net income

−$165M

latest annual

Shares out

307M

Free cash flow

−$120M

52-week range

Current: 12.27

▲

Low

5.25

High

14.82

Quality score

45/100

D

Growth63

Business quality0

missing: grossMargin

Financial health80

Valuation39

missing: peRatio

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.